Skip to main content
OpenTrials

Clinical trial condition

Attention Deficit/Hyperactivity Disorder

Explore clinical trials studying Attention Deficit/Hyperactivity Disorder. Study availability and eligibility vary by location and protocol.

23 public trials 2 recruiting studies
Refine in advanced search Browse all conditions

Attention Deficit/Hyperactivity Disorder trial results

Completed

Open-label Extension Evaluating Methylphenidate Hydrochloride Extended Release in Adults With Attention Deficit/Hyperactivity Disorder

NCT01338818

Conditions
Attention Deficit Disorder with Hyperactivity, Attention Deficit and Disruptive Behavior Disorders, Attention Deficit/Hyperactivity Disorder, +8 more
Locations
  • Novartis Investigative Site Little Rock, Arkansas, United States
  • Novartis Investigative Site Beverly Hills, California, United States
  • Novartis Investigative Site Spring Valley, California, United States
  • Novartis Investigative Site Bradenton, Florida, United States
View all 48 locations
View Trial Details
Completed

Efficacy and Safety Study of Methylphenidate Hydrochloride Extended Release in Adults With Childhood-onset Attention Deficit/Hyperactivity Disorder (ADHD)

NCT01259492

Conditions
Attention Deficit Disorder with Hyperactivity, Attention Deficit and Disruptive Behavior Disorders, Attention Deficit/Hyperactivity Disorder, +2 more
Locations
  • Novartis Investigative Site Little Rock, Arkansas, United States
  • Novartis Investigative Site Beverly Hills, California, United States
  • Novartis Investigative Site Spring Valley, California, United States
  • Novartis Investigative Site Bradenton, Florida, United States
View all 68 locations
View Trial Details

Related conditions